secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001477932-25-008932
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx subsidiary CEO Dr. Butera to depart Jan 31, 2026; position eliminated
--------------------------------------------------------------------------------

- Volition Veterinary CEO Dr. Salvatore Thomas Butera given termination notice, effective Jan 31, 2026.
- CEO position eliminated as part of ongoing cost-realignment efforts; duties redistributed.
- Dr. Butera expected to stay as part-time consultant post-termination under agreed terms.
- Departure not due to any disagreement with company on operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793225008932/0001477932-25-008932-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793225008932/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-008932

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer